Home › Small Cell Lung Cancer › Pennsylvania › Pittsburgh
Small Cell Lung Cancer clinical trials in Pittsburgh, PA
5 studies for Small Cell Lung Cancer are looking for participants at sites in and around Pittsburgh (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
RecruitingPhase 1/2
- University of Pittsburgh Medical Center, Pittsburgh
DAREON ® -Lung-1: A Study in People With Advanced Small Cell Lung Cancer to Compare Obrixtamig Plus Atezolizumab, Carboplatin, and Etoposide Treatment With Standard Chemoimmunotherapy
RecruitingPhase 3
- AHN Cancer Institute - Allegheny General, Pittsburgh
A Study of ZL-1310 Versus Investigator's Choice of Therapy in Participants With Relapsed Small Cell Lung Cancer (DLLEVATE)
RecruitingPhase 3
- Allegheny General Hospital, Pittsburgh
- University of Pittsburgh (UPMC) Hillman Cancer Center, Pittsburgh
Phase II Study of Platinum/Etoposide Plus Ivonescimab for Extensive-Stage Small Cell Lung Cancer
RecruitingPhase 2
- UPMC Hillman Cancer Center, Pittsburgh
Biomarker Directed Trial of Temozolomide and Stenoparib in Relapsed SCLC
RecruitingPhase 1/2
- VA Pittsburgh Healthcare System University Drive Division, Pittsburgh, PA, Pittsburgh
Small Cell Lung Cancer trials in other cities
- Houston, TX26 studies
- Arlington, VA23 studies
- Boston, MA21 studies
- New York City, NY21 studies
- Nashville, TN20 studies
- Los Angeles, CA20 studies
- Orlando, FL15 studies
- Dallas, TX13 studies
- St. Louis, MO13 studies
- Cleveland, OH13 studies
- Detroit, MI12 studies
- Chicago, IL12 studies
Other studies in Pittsburgh
- Non-Small Cell Lung Cancer48 studies
- Cancer (all types)41 studies
- Breast Cancer39 studies
- Colorectal Cancer32 studies
- Metastatic Cancer31 studies
- Melanoma31 studies
- Ovarian Cancer30 studies
- Endometrial Cancer23 studies
- Lung Cancer23 studies
- Prostate Cancer23 studies
- Stroke22 studies
- Head and Neck Squamous Cell Carcinoma22 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.